167 related articles for article (PubMed ID: 16186795)
1. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA; Duan H; Garcia PB; Boxer LM
Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
Heckman CA; Wheeler MA; Boxer LM
Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
[TBL] [Abstract][Full Text] [Related]
3. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Boxer LM
Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
[TBL] [Abstract][Full Text] [Related]
5. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.
Heckman CA; Cao T; Somsouk L; Duan H; Mehew JW; Zhang CY; Boxer LM
Cancer Res; 2003 Oct; 63(20):6666-73. PubMed ID: 14583460
[TBL] [Abstract][Full Text] [Related]
6. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif.
Felli MP; Moschella C; Farina AR; Alesse E; Screpanti I; Teti D; Frati L; Gulino A
Cell Immunol; 1996 Sep; 172(2):229-34. PubMed ID: 8964085
[TBL] [Abstract][Full Text] [Related]
9. Glutamate-induced octamer DNA binding and transcriptional control in cultured radial glia cells.
López-Bayghen E; Cruz-Solís I; Corona M; López-Colomé AM; Ortega A
J Neurochem; 2006 Aug; 98(3):851-9. PubMed ID: 16787415
[TBL] [Abstract][Full Text] [Related]
10. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
11. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
12. Btk expression is controlled by Oct and BOB.1/OBF.1.
Brunner C; Wirth T
Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
[TBL] [Abstract][Full Text] [Related]
13. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
Arcinas M; Heckman CA; Mehew JW; Boxer LM
Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
[TBL] [Abstract][Full Text] [Related]
15. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
[TBL] [Abstract][Full Text] [Related]
16. Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization.
Romero F; Martínez-A C; Camonis J; Rebollo A
EMBO J; 1999 Jun; 18(12):3419-30. PubMed ID: 10369681
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
Fiala-Beer E; Lee AC; Murray M
Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
[TBL] [Abstract][Full Text] [Related]
18. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
19. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
Duan H; Xiang H; Ma L; Boxer LM
Oncogene; 2008 Dec; 27(53):6720-8. PubMed ID: 18695675
[TBL] [Abstract][Full Text] [Related]
20. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis.
Kondo E; Yoshino T
Pathol Int; 2007 Jul; 57(7):391-7. PubMed ID: 17587238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
